Read, Watch or Listen

Virginia Tech researchers report that GLP-1 drugs may blunt alcohol’s immediate effects. In a small pilot study of 20 adults with obesity, half taking semaglutide, tirzepatide, or liraglutide reached the same 0.08% blood alcohol level after three drinks, but their BAC rose more slowly and they felt less intoxicated, with lower alcohol craving before and after the session. Published in Scientific Reports, the findings hint that slowed gastric emptying and other peripheral actions could temper alcohol’s effects and craving, though the authors stress larger studies are needed.

Prepared by Olivia Bennett and reviewed by editorial team.